AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results

Core Insights - AirSculpt Technologies, Inc. reported a revenue decline of 13.7% year-over-year for Q2 2025, totaling $44.0 million compared to $51.0 million in Q2 2024 [8] - The company narrowed its year-over-year revenue decline by four percentage points compared to Q1 2025, indicating a potential recovery trend [2] - AirSculpt's case volume decreased by 14.1% in Q2 2025, with 3,392 cases compared to 3,949 in Q2 2024 [8] Financial Performance - For the first six months of 2025, revenue declined 15.5% to $83.4 million from $98.6 million in the same period of 2024 [8] - The net loss for Q2 2025 was $0.6 million, an improvement from a net loss of $3.2 million in Q2 2024 [8] - Adjusted EBITDA for Q2 2025 was $5.8 million, down from $6.9 million in Q2 2024, reflecting a decrease in profitability [8] Strategic Initiatives - The company is piloting two new offerings: skin tightening procedures and expanded financing options for consumers, aimed at enhancing growth strategies [2] - AirSculpt has successfully reduced its debt by $16 million in Q2 2025 following a common stock offering in June [2] - The company maintains its full-year 2025 revenue and adjusted EBITDA guidance, projecting revenues between $160 million and $170 million and adjusted EBITDA of approximately $16 million to $18 million [5][8] Liquidity and Capital Structure - As of June 30, 2025, AirSculpt had $8.2 million in cash and cash equivalents, with an additional $5.0 million available under its revolving credit facility [6] - The company generated $5.9 million in operating cash flow for the first half of 2025, compared to $6.8 million for the same period in 2024 [6] - AirSculpt's total liabilities decreased to $107.2 million from $130.7 million year-over-year, indicating improved financial health [24]